VRTX Balance Sheet
Vertex Pharmaceuticals Inc - Assets, Liabilities & Stockholders' Equity
Total Assets
$25.64B
Total Liabilities
$6.98B
Shareholders' Equity
$18.67B
Cash Position
$5.08B
Assets
As of: FY
Current Assets
Cash & Equivalents
$5.08B
Total Current Assets
$11.20B
Non-Current Assets
Total Assets
$25.64B
Liabilities & Equity
Current Liabilities
Total Current Liabilities
$3.86B
Non-Current Liabilities
Total Liabilities
$6.98B
Stockholders' Equity
Retained Earnings
$13.56B
Total Equity
$18.67B
Total Liabilities & Equity
$25.64B
Should equal Total Assets
Key Balance Sheet Ratios
Current Ratio
2.90
Current Assets / Current Liabilities
Working Capital
$7.34B
Current Assets - Current Liabilities
Balance Sheet Health
Liquidity: Strong
Current ratio of 2.90 indicates the company has ample short-term assets to cover short-term liabilities.
Cash Position: 19.8% of Assets
$5.08B in cash provides strong financial flexibility.
View Complete Financial Analysis
Explore detailed financials, income statements, cash flows, and more
Open Full FinancialsFrequently Asked Questions
What are VRTX's total assets?
VRTX has total assets of $25.64B, up from $22.53B in the previous period.
How much debt does VRTX have?
Debt information for VRTX can be found in the balance sheet.
What is VRTX's cash position?
VRTX has $5.08B in cash and cash equivalents, representing 19.8% of total assets.
What is VRTX's stockholders' equity?
VRTX's stockholders' equity is $18.67B. This represents the book value of the company and shareholder ownership stake.
What is VRTX's current ratio?
VRTX has a current ratio of 2.90. This means the company has $2.90 in current assets for every $1 in current liabilities. A ratio above 1.0 indicates good short-term financial health.
How healthy is VRTX's balance sheet?
VRTX's balance sheet shows $25.64B in total assets, $6.98B in liabilities, and $18.67B in equity. The current ratio of 2.90 suggests strong liquidity.